Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
65
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Biocytogen Pharmaceuticals (Beijing)
•
16 Feb 2022 09:14
Pre-IPO Biocytogen Pharmaceuticals - The Novel Development Model Offset the Pipeline's Shortcomings
We analyzed the unique development strategy of Biocytogen, and also pointed out the concerns on its pipeline. However, its business model is hard...
Xinyao (Criss) Wang
Follow
275 Views
Share
bullish
•
SenseTime Group
•
25 Jan 2022 08:58
HSCI Index Rebalance and Stock Connect: Plenty of New Listings Should Be Included
There could be up to 34 adds and 22 deletes for the HSCI in March based on market cap, liquidity and prolonged suspensions. A lot of new listings,...
Brian Freitas
Follow
496 Views
Share
bullish
•
Keymed Biosciences
•
16 Dec 2021 09:15
Keymed Biosciences (2162.HK) - The Pipeline, the Concerns on Valuation Growth & The Trading Strategy
This article mainly analyzed Keymed in terms of the business, the core and key candidates in the pipeline, the concerns about valuation growth...
Xinyao (Criss) Wang
Follow
275 Views
Share
bearish
•
Shanghai Junshi Biosciences
•
14 Dec 2021 09:15
Shanghai Junshi Bioscience (1877.HK) - Will Junshi Progress or Go Backwards Instead?
The article mainly analyzed Junshi in terms of the pipeline, commercialization strategy, the talents, the outlook, the related concerns, as well as...
Xinyao (Criss) Wang
Follow
249 Views
Share
bullish
•
Orient Overseas International
•
08 Dec 2021 12:18
HSCI Index Rebalance and Stock Connect: More Inclusions than Exclusions in March
We expect there will be a lot more inclusions than exclusions at the March rebalance of the HSCI. The changes to the index will result in changes...
Brian Freitas
Follow
467 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x